Human noroviruses, GII.4 strains in particular, are the chief drivers of acute viral gastroenteritis around the world, a condition for which there are no vaccines or antivirals. Understanding how ...
HIEs were used to identify why the growth of norovirus in culture stops and to determine methods to maintain growth.
News-Medical.Net on MSN
Breakthrough enables continuous laboratory growth of human norovirus
Researchers at Baylor College of Medicine report in Science Advances a breakthrough in human norovirus (HuNoV) research. Norovirus is a leading cause of acute viral gastroenteritis worldwide with ...
Researchers at Baylor College of Medicine report in Science Advances a breakthrough in human norovirus (HuNoV) research. Norovirus is a leading cause of acute viral gastroenteritis worldwide with ...
Researchers have developed a simple and efficient system for understanding the functions of specific norovirus genes, providing new avenues for developing antivirals and vaccines. Norovirus is the ...
Cocrystal Pharma, Inc. announced that its investigational antiviral drug CDI-988 has shown strong efficacy against the newly dominant norovirus variants GII.17 and previously prevalent GII.4, amid a ...
Human noroviruses, GII.4 strains in particular, are the chief drivers of acute viral gastroenteritis around the world, a condition for which there are no vaccines or antivirals. Understanding how ...
Human noroviruses, GII.4 strains in particular, are the chief drivers of acute viral gastroenteritis around the world, a condition for which there are no vaccines or antivirals. Understanding how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results